由Atul Verma博士牵头的加拿大的一项研究介绍了一种更安全、更简单的治疗非正常心跳的方法,减少了出血和摔倒等风险。 A Canadian study led by Dr. Atul Verma introduces a safer, simpler treatment for irregular heartbeats, reducing risks like bleeding and falls.

McGill大学保健中心的Atul Verma博士在加拿大牵头进行的一项研究为非正常心跳开发了一种更安全、更简单的治疗方法,有可能降低出血和与当前疗法有关的下降风险。 A Canadian-led study by Dr. Atul Verma at McGill University Health Centre has developed a safer, simpler treatment for irregular heartbeats, potentially reducing risks like bleeding and falls linked to current therapies. 该研究主要由加拿大卫生研究所供资,在没有产业影响的情况下进行,涉及多个学术中心,被称赞为公共资助的医学研究的一大进步。 Funded primarily by the Canadian Institutes of Health Research and conducted without industry influence, the research involved multiple academic centers and is praised as a major advancement in publicly funded medical research. 专家说,这标志着病人护理向前迈出了一大步,并突显了加拿大在高质量、以病人为中心的临床试验方面的领导作用。 Experts say it marks a significant step forward for patient care and highlights Canada’s leadership in high-quality, patient-centered clinical trials.